Trials / Completed
CompletedNCT04442477
Neurodevelopment at 5.5 Years of Age in Children Who Received Infant Formula With Enriched Protein Fractions
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 116 (actual)
- Sponsor
- Mead Johnson Nutrition · Industry
- Sex
- All
- Age
- 64 Months – 68 Months
- Healthy volunteers
- Accepted
Summary
This is a follow-up study of a multi-center, double-blind, randomized, controlled, parallel-designed, prospective trial and is intended to evaluate neurodevelopment at 5.5 years of age and health outcomes through 5.5 years of age in participants who received one of two staged study formulas through one year of age.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Enriched Protein Fractions | Enriched protein fractions |
| DIETARY_SUPPLEMENT | Protein Fraction | Protein fractions |
Timeline
- Start date
- 2020-06-15
- Primary completion
- 2021-05-27
- Completion
- 2021-05-27
- First posted
- 2020-06-22
- Last updated
- 2021-12-16
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT04442477. Inclusion in this directory is not an endorsement.